NIFTY 50

Biocon Q3 earnings today: Here's what to expect

Updated : January 24, 2019 12:24 PM IST

Indian biopharmaceutical company Biocon is set to report its third quarter results on Thursday. Here are key factors to watch out for:

  • It is expected to be a strong quarter for the company.

  • The revenue is likely to grow around 30 percent.

  • Margin expansion of around 400 basis points seen, led by higher margin products. One basis point is a hundredth of a percentage point.

  • Profit is expected to see a growth of 79 percent.

  • Within the biosimilar business, the one thing which is going to drive growth will be the launch of Pegfilgrastim in the US, the cancer biosimilar.

  • Branded formulation segment is likely to follow biologics with strong growth of 20-25 percent.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV